Browse All Articles by Topic

New HPV vaccine covers 9 types of HPV

Get ready to include a new human papillomavirus (HPV) vaccine at your facility. The Food and Drug Administration (FDA) has approved Gardasil 9 from Kenilworth, NJ-based Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.

Some groups continue to bear disproportionate burden of STIs

While the latest national surveillance data show signs of progress in reducing chlamydia and gonorrhea among young people ages 15-24, the numbers and rates of reported cases of these two diseases continue to be highest in this group compared to other age groups.¹

Health plan brings weight management to members in the community

Capital District Physicians’ Health Plan (CDPHP) is expanding its Weigh 2 Be weight-management program in hopes of reducing the rise in preventable diseases caused by obesity.

Research focuses on health implications tied to PCOS

Women diagnosed with polycystic ovary syndrome (PCOS) face an elevated risk of developing heart disease, diabetes, mental health conditions, reproductive disorders, and cancer of the lining of the uterus.

More emphasis needed on vaccination for HPV — What is your approach?

A new analysis of national data indicates about half of girls in the United States receive the human papillomavirus (HPV) vaccine at the recommended age.

Remind all women about importance of folic acid

While fortifying grain foods with the B vitamin folic acid has saved about 1,300 babies every year from being born with serious birth defects of the brain and spine known as neural tube defects (NTDs), women of reproductive age still should be counseled to take a multivitamin with folic acid every day.

Scientists eye impact of expedited partner therapy

Results of a public health intervention promoting the use of free expedited partner therapy (EPT) indicate it substantially increased use of the medicine and might have cut rates of chlamydia and gonorrhea infection.

HPV screening: Option to cytology-based options

Primary human papillomavirus (HPV) screening can be considered as an alternative to current U.S. cytology-based cervical cancer screening methods, according to new interim guidance from two leading medical societies.

Data reaffirm the effectiveness of LNG, copper intrauterine devices

Findings from a recent analysis of data from a large, multi-country study of women using levonorgestrel or copper intrauterine devices (IUDs) indicate that while both forms of contraception have high levels of efficacy, the levonorgestrel device daily releasing 20 mcg was associated with a significantly lower risk of pregnancy, including ectopic pregnancy, than copper IUDs.

Topical Curcumin for Treatment of Lactational Mastitis

In comparison to placebo, topical curcumin improves markers of lactational mastitis within 72 hours of administration.